Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Sympathetic Overactivity in Metabolic Syndrome
NCT00408850Phase 3Unknown
- Sponsor
- Baker Heart and Diabetes Institute
- Start
- Nov 2008
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in metabolic syndrome, sponsored by Baker Heart and Diabetes Institute. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00408850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408850.